✦ LIBER ✦

A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: Final results of the ZoMaxx II trial

✍ Scribed by William A. Gray; Alan C. Yeung; Donald E. Cutlip; Jeffrey J. Popma; Peter J. Fitzgerald; David O. Williams; Hubertus Heuer; Charles D. O'Shaughnessy; Paul A. Overlie; J. Tift Mann; Louis A. Cannon; James B. Hermiller; Timothy D. Henry; Robert Whitbourn; Thomas D. Stuckey; Mark G. Midei; Jessie Coe; Lewis B. Schwartz

Book ID: 116550078
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 382 KB
Volume: 157
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2011.05.061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Zotarolimus-Eluting Stents

Comparison of Zotarolimus-Eluting Stents With Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization: The ZEST (Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent with Sirolimus-Eluting and PacliTaxel-Eluting Stent for Coronary Lesions) Randomized Trial

✍ Duk-Woo Park; Young-Hak Kim; Sung-Cheol Yun; Soo-Jin Kang; Seung-Whan Lee; Cheol 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 696 KB

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB

TCT-404: Late Safety and Efficacy of a Z

TCT-404: Late Safety and Efficacy of a Zotarolimus-Eluting Stent Compared with a Paclitaxel-Eluting Stent in Patients with De Novo Coronary Lesions: Three-Year Follow-up from the ENDEAVOR IV Trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Comparison of the efficacy and safety of

Comparison of the efficacy and safety of paclitaxel-eluting coroflex please stents and paclitaxel-eluting stents in patients with coronary artery disease: A randomized PIPA trial

✍ Hyun-Sook Kim; Seung-Jung Park; Duk-Woo Park; Seong-Wook Park; Sang-Sig Cheong; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 901 KB

A Randomized Comparison of the Endeavor

A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions: 12-Month Outcomes From the ENDEAVOR IV Trial

✍ Martin B. Leon; Laura Mauri; Jeffrey J. Popma; Donald E. Cutlip; Eugenia Nikolsk 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 923 KB

AS-051 Comparison of the Efficacy and Sa

AS-051 Comparison of the Efficacy and Safety of Paclitaxel-Eluting CoroflexTM Please Stent versus Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease: The PIPA Randomized Controlled Trial

✍ Jung-Min Ahn; Young-Hak Kim; Hyun-Sook Kim; Duk-Woo Park; Sang-Sig Cheong; Bong- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 294 KB